Hana Biosciences, Inc. Announces Third Quarter 2006 Results

November 3, 2006 |

1 min read

SAN FRANCISCO, Nov. 2, 2006 (PRIMEZONE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, today announced financial results for the third quarter of 2006.

Earnings

MORE ON THIS TOPIC

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Merck To Cut 125 Employees as It Ends UK R&D Work

September 12, 2025

·

198 min read

·

BioSpace Editorial Staff

AbbVie headquarters building facade of an American publicly traded biopharmaceutical company. - South San Francisco, California, USA - 2021

Patents

AbbVie Adds Four Years of Exclusivity to Rinvoq Franchise With Generics Settlement

September 12, 2025

·

2 min read

·

Tristan Manalac

Crisis. Sanctions. Withdrawal of investment and capital. Stop participation. The collapse of the company, the split of business partners.

Autoimmune disease

Intercept Withdraws Embattled Liver Drug from US Market

September 12, 2025

·

2 min read

·

Tristan Manalac

Glowing red up arrow surrounded by dollar signs in black background. Illustration of the concept of positive return on investment and business earnings

IPO

UPDATE: Neuroscience Biotech LB Pulls Off Upsized $285M IPO

September 11, 2025

·

2 min read

·

Annalee Armstrong